Evidence map›Paper›PMID 31861982›Full record

ArticleBMC bioinformatics2019

Biological representation of chemicals using latent target interaction profile.

Mohamed Ayed, Hansaim Lim, Lei Xie

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. A review on machine learning approaches and trends in drug discovery.Computational and structural biotechnology journal · 2021
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed AyedPh.D. Program in Computer Science, The Graduate Center, The City University of New York, New York, NY, USA.
Hansaim LimPh.D. Program in Biochemistry, The Graduate Center, The City University of New York, New York, NY, USA.
Lei XieDepartment of Computer Science, Hunter College, & The Graduate Center, The City University of New York, New York, NY, USA. lei.xie@hunter.cuny.edu.

Funding

Drug repurposing for Alzheimer's disease using structural systems pharmacology.R01AG057555 · NIA · NORTHEASTERN UNIVERSITY · PI Lei Xie · 2018 to 2026
$6.7M
Omics data integration and analysis for structure-based multi-target drug designR01GM122845 · NIGMS · NORTHEASTERN UNIVERSITY · PI Lei Xie · 2017 to 2026
$3.0M
Drug discovery by integrating chemical genomics and structural systems biologyR01LM011986 · NLM · HUNTER COLLEGE · PI BRINKMAN, FIONA, BURLEY, STEPHEN K · 2014 to 2017
$1.2M
NIA NIH HHS R01 AG057555NIGMS NIH HHS R01 GM122845NLM NIH HHS R01 LM011986
6 · The paper itself

Abstract

backgroundComputational prediction of a phenotypic response upon the chemical perturbation on a biological system plays an important role in drug discovery, and many other applications. Chemical fingerprints are a widely used feature to build machine learning models. However, the fingerprints that are derived from chemical structures ignore the biological context, thus, they suffer from several problems such as the activity cliff and curse of dimensionality. Fundamentally, the chemical modulation of biological activities is a multi-scale process. It is the genome-wide chemical-target interactions that modulate chemical phenotypic responses. Thus, the genome-scale chemical-target interaction profile will more directly correlate with in vitro and in vivo activities than the chemical structure. Nevertheless, the scope of direct application of the chemical-target interaction profile is limited due to the severe incompleteness, biasness, and noisiness of bioassay data.

resultsTo address the aforementioned problems, we developed a novel chemical representation method: Latent Target Interaction Profile (LTIP). LTIP embeds chemicals into a low dimensional continuous latent space that represents genome-scale chemical-target interactions. Subsequently LTIP can be used as a feature to build machine learning models. Using the drug sensitivity of cancer cell lines as a benchmark, we have shown that the LTIP robustly outperforms chemical fingerprints regardless of machine learning algorithms. Moreover, the LTIP is complementary with the chemical fingerprints. It is possible for us to combine LTIP with other fingerprints to further improve the performance of bioactivity prediction.

conclusionsOur results demonstrate the potential of LTIP in particular and multi-scale modeling in general in predictive modeling of chemical modulation of biological activities.

Indexed as

Drug DiscoveryAlgorithmsMachine LearningBioactivityChemical embeddingFingerprintGenome-wide target bindingLTIPMachine learning

Identifiers

PMID31861982
PMCPMC6924142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.